Our data suggest that levels of SPARC are reduced in islets from donors with diabetes and that it has a role in insulin secretion, an effect which appears independent of SPARC’s modulation of obesity-induced insulin resistance in adipose tissue. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.